Citadel Advisors’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82.2K Sell
12,900
-44,900
-78% -$312K ﹤0.01% 12157
2025
Q4
$407K Sell
57,800
-222,000
-79% -$1.34M ﹤0.01% 9498
2025
Q3
$1.54M Sell
279,800
-27,800
-9% -$136K ﹤0.01% 6610
2025
Q2
$1.59M Buy
307,600
+139,500
+83% +$836K ﹤0.01% 6154
2025
Q1
$1.12M Sell
168,100
-91,400
-35% -$695K ﹤0.01% 6714
2024
Q4
$1.91M Sell
259,500
-186,200
-42% -$1.34M ﹤0.01% 5728
2024
Q3
$3.12M Buy
445,700
+154,400
+53% +$928K ﹤0.01% 4707
2024
Q2
$1.43M Buy
291,300
+30,500
+12% +$184K ﹤0.01% 5919
2024
Q1
$1.61M Buy
260,800
+158,700
+155% +$1.07M ﹤0.01% 5943
2023
Q4
$799K Buy
102,100
+48,000
+89% +$309K ﹤0.01% 7130
2023
Q3
$372K Buy
54,100
+16,800
+45% +$136K ﹤0.01% 8705
2023
Q2
$341K Buy
37,300
+23,300
+166% +$194K ﹤0.01% 8762
2023
Q1
$104K Sell
14,000
-1,100
-7% -$6.1K ﹤0.01% 11202
2022
Q4
$74.6K Sell
15,100
-5,200
-26% -$32.2K ﹤0.01% 11621
2022
Q3
$134K Sell
20,300
-5,100
-20% -$35.6K ﹤0.01% 10828
2022
Q2
$141K Sell
25,400
-12,500
-33% -$95.7K ﹤0.01% 11046
2022
Q1
$383K Sell
37,900
-10,500
-22% -$92.2K ﹤0.01% 10022
2021
Q4
$461K Sell
48,400
-33,600
-41% -$356K ﹤0.01% 9899
2021
Q3
$1.19M Buy
+82,000
New +$1.58M ﹤0.01% 7704

Other funds holding LFST

Citadel Advisors's LFST Position: Q1 2026 in Review

Citadel Advisors increased its Lifestance Health (LFST) stake by 9,568% in Q1 2026, buying an estimated $26.5M and bringing the position to 3,850,026 shares worth $24.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2087.

Citadel Advisors first reported a position in LFST in Q2 2021 and has held it in 19 quarters since. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Citadel Advisors held 3,850,026 shares of Lifestance Health worth $24.5M as of Q1 2026.
  • Citadel Advisors bought 3,810,205 Lifestance Health shares in Q1 2026, an estimated $26.5M.
  • Lifestance Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2087 holding.
  • Citadel Advisors first reported a position in Lifestance Health in Q2 2021 and has held it in 19 quarters since.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.